Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Recorded changes
86,510 on record
Recorded policy changes, newest first| Recorded | Payer | Policy | Change |
|---|
| May 18, 2026 | Regence BCBS | Genetic Testing for CADASIL SyndromePayerPolicy · REGENCE-GT51 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Genetic Testing for Biallelic RPE65 Variant-Associated Retinal DystrophyPayerPolicy · REGENCE-GT21 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Genetic and Molecular Diagnostic TestingPayerPolicy · REGENCE-GT20 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Gene-Based Tests for Screening,Detection,and Management of Prostate or Bladder CancerPayerPolicy · REGENCE-GT17 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Gene Expression Profiling for MelanomaPayerPolicy · REGENCE-GT29 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Folate TestingPayerPolicy · REGENCE-LAB79 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Extracranial Carotid Angioplasty and StentingPayerPolicy · REGENCE-SUR93 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Expanded Molecular Testing of Cancers to Select Targeted TherapiesPayerPolicy · REGENCE-GT83 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Electromagnetic TherapyPayerPolicy · REGENCE-DME83.13 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Electromagnetic Navigation BronchoscopyPayerPolicy · REGENCE-SUR179 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Electrical Bone Growth Stimulators (Osteogenic Stimulation)PayerPolicy · REGENCE-DME83.11 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Donor Lymphocyte Infusion for Malignancies Treated with an Allogeneic Hematopoietic Cell TransplantPayerPolicy · REGENCE-TRA45.03 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Digital Therapeutic Products for Substance Use DisordersPayerPolicy · REGENCE-MED175.02 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Digital Therapeutic Products for Chronic Low Back PainPayerPolicy · REGENCE-MED175.03 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Digital Therapeutic ProductsPayerPolicy · REGENCE-MED175 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Diagnostic Genetic Testing for α-ThalassemiaPayerPolicy · REGENCE-GT52 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Diagnostic Genetic Testing for FMR1 and AFF2 Variants (including Fragile X and Fragile XE Syndromes)PayerPolicy · REGENCE-GT43 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Cryosurgical Ablation of Miscellaneous Solid Tumors Outside of the LiverPayerPolicy · REGENCE-SUR132 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Cranial Electrostimulation Therapy (CES)PayerPolicy · REGENCE-DME83.06 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | COVID-19 TestingPayerPolicy · REGENCE-LAB74 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Cosmetic and Reconstructive ProceduresPayerPolicy · REGENCE-SUR12 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Cooling Devices Used in the Home SettingPayerPolicy · REGENCE-DME07 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Confocal Laser EndomicroscopyPayerPolicy · REGENCE-MED151 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | ClonoSEQ Testing for the Assessment of Measurable Residual Disease (MRD)PayerPolicy · REGENCE-GT88 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Chemical PeelsPayerPolicy · REGENCE-SUR12.50 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Charged-Particle (Proton) RadiotherapyPayerPolicy · REGENCE-MED49 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Cell Therapy for Peripheral Arterial DiseasePayerPolicy · REGENCE-MED141 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Bronchial ThermoplastyPayerPolicy · REGENCE-SUR178 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Blepharoplasty, Repair of Blepharoptosis, and Brow Ptosis RepairPayerPolicy · REGENCE-SUR12.05 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Bioimpedance Devices for Detection and Management of LymphedemaPayerPolicy · REGENCE-DME82 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | BiofeedbackPayerPolicy · REGENCE-AH32 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Bioengineered Skin and Soft Tissue Substitutes and Amniotic ProductsPayerPolicy · REGENCE-MED170 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Benign Prostatic Hyperplasia Surgical TreatmentsPayerPolicy · REGENCE-SUR210 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Bariatric SurgeryPayerPolicy · REGENCE-SUR58 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Auricular ElectrostimulationPayerPolicy · REGENCE-MED146 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Applied Behavior Analysis Initial Assessment for the Treatment of Autism Spectrum DisordersPayerPolicy · REGENCE-BH33 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Anterior Abdominal Wall (Including Incisional) Hernia RepairPayerPolicy · REGENCE-SUR12.03 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Amplitude-Modulated Radiofrequency Electromagnetic Fields (AM RF-EMF) for Cancer TreatmentPayerPolicy · REGENCE-DME96 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndromes and Myeloproliferative NeoplasmsPayerPolicy · REGENCE-TRA45.24 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Allogeneic Hematopoietic Cell Transplantation for Genetic Diseases and Acquired AnemiasPayerPolicy · REGENCE-TRA45.25 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Air Ambulance TransportPayerPolicy · REGENCE-UM13 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | Administrative Guidelines to Determine Dental vs Medical ServicesPayerPolicy · REGENCE-AH35 | Criteria changed |
|---|
| May 18, 2026 | Regence BCBS | ActigraphyPayerPolicy · REGENCE-MED125 | Criteria changed |
|---|
| May 18, 2026 | BCBS Oklahoma | WilatePayerPolicy · BCBSOK-RX501.160 | Criteria changed |
|---|
| May 18, 2026 | BCBS Oklahoma | Vutrisiran (Amvuttra) and Patisiran (Onpattro)PayerPolicy · BCBSOK-RX501.146 | Criteria changed |
|---|
| May 18, 2026 | BCBS Oklahoma | Viscocanalostomy and CanaloplastyPayerPolicy · BCBSOK-SUR713.032 | Criteria changed |
|---|
| May 18, 2026 | BCBS Oklahoma | Vestibular Function TestingPayerPolicy · BCBSOK-MED201.047 | Criteria changed |
|---|
| May 18, 2026 | BCBS Oklahoma | Vertical Expandable Prosthetic Titanium RibPayerPolicy · BCBSOK-SUR705.025 | Criteria changed |
|---|
| May 18, 2026 | BCBS Oklahoma | Ventricular Assist Devices and Total Artificial HeartsPayerPolicy · BCBSOK-SUR707.017 | Criteria changed |
|---|
| May 18, 2026 | BCBS Oklahoma | VedolizumabPayerPolicy · BCBSOK-RX501.117 | Criteria changed |
|---|